V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004141 | 290006420 | 1.56 | 41.7 | Palliative (P) | 2016-04-17 | 2016-05-04 | Capecitabine | N | Y | 290020637 | CHOP R |
| 290004142 | 290003065 | 1.7 | 93 | Curative (C) | 2015-11-11 | 2015-11-15 | Cisplatin + Docetaxel +Fluorouracil | 2 | Y | 290020640 | CAPECITABINE + RT |
| 290004143 | 290003066 | 1.53 | 68 | Palliative (P) | 2017-12-27 | 2018-01-10 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | 290020642 | CETUXIMAB + CISPLATIN + FU |
| 290004144 | 290003066 | 1.74 | null | Palliative (P) | 2014-04-01 | 2014-04-15 | Capecitabine | N | N | 290020642 | ECX |
| 290004145 | 290003067 | 1.75 | 86.4 | Curative (C) | 2017-07-28 | 2017-08-16 | PACLITAXEL | 02 | Y | 290020647 | IRINOTECAN + MDG |
| 290004146 | 290003067 | 1.68 | null | Palliative (P) | 2014-01-06 | 2014-01-12 | Capecitabine | N | N | 290020647 | PLATO TRIAL |
| 290004147 | 290003068 | 1.53 | 105 | Neo-adjuvant (N) | 2014-10-05 | 2014-10-19 | Cetuximab + CISPLATIN + FLUOROURACIL | N | N | 290020649 | BEVACIZUMAB + CAPECITABINE |
| 290004148 | 290003069 | 1.82 | 79.8 | Palliative (P) | 2013-12-24 | 2014-01-27 | Carbo F | N | N | 290020652 | CISPLATIN + FLUOROURACIL |
| 290004149 | 290003070 | 1.67 | 41.1 | null | 2013-09-23 | 2013-09-23 | CARBO + FLUOROURACIL | 02 | null | 290020655 | RUXOLITINIB |
| 290004150 | 290003071 | 0 | 65.6 | Palliative (P) | null | 2016-04-18 | CISPLATIN + FLUOROURACIL | N | N | 290020656 | KESTREL TRIAL |
| 290004151 | 290003071 | null | 50.3 | Palliative (P) | 2018-04-11 | 2018-04-16 | IDARUBICIN | 02 | N | 290020656 | CARBOPLATIN |
| 290004152 | 290003072 | 1.63 | 68.2 | Curative (C) | 2015-05-01 | 2015-05-15 | LANREOTIDE | 02 | N | 290020661 | CAPECITABINE + RT |
| 290004153 | 290003073 | 1.65 | 87.1 | Palliative (P) | 2015-10-02 | 2015-10-15 | Fluorouracil + Folinic Acid Weekly | 2 | null | 290020664 | EOX |
| 290004154 | 290003074 | null | null | Neo-adjuvant (N) | 2013-10-29 | 2013-10-31 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020665 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004155 | 290003075 | 1.84 | 85 | Adjuvant (A) | 2015-07-14 | 2015-07-27 | Y-90 | N | N | 290020669 | PLATO TRIAL |
| 290004156 | 290003076 | null | 54.45 | Not known (9) | null | 2015-08-27 | ECX | N | N | 290020672 | CARBOPLATIN |
| 290004157 | 290003077 | 1.76 | 67.7 | Neo-adjuvant (N) | 2013-09-27 | 2013-10-16 | Cisplatin + Etoposide po&iv 3 day | N | N | 290020673 | CAPECITABINE + TEMOZOLOMIDE |
| 290004158 | 290003078 | 1.68 | 47 | Curative (C) | 2017-05-28 | 2017-06-24 | Carboplatin + Etoposide iv&po | N | N | 290020674 | CAPECITABINE |
| 290004159 | 290003078 | 1.53 | 67.6 | null | 2016-12-12 | 2017-01-03 | Capecitabine | N | N | 290020674 | FLUOROURACIL + STREPTOZOCIN |
| 290004160 | 290003079 | 1.75 | 118 | Palliative (P) | 2015-08-17 | 2015-08-17 | Capecitabine 35days + RT | 02 | null | 290020677 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 290004161 | 290003080 | null | null | null | 2016-01-31 | 2016-02-10 | PACLITAXEL | N | N | 290020678 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004162 | 290003080 | 1.68 | null | Curative (C) | 2017-09-08 | 2017-09-13 | CISPLATIN + FLUOROURACIL | N | N | 290020678 | CISPLATIN + FLUOROURACIL |
| 290004163 | 290003081 | 1.65 | 56 | null | 2013-08-14 | 2013-08-21 | EOX | 2 | null | 290020680 | GEMCARBO |
| 290004164 | 290006426 | 1.53 | 61.8 | Adjuvant (A) | 2013-05-31 | 2013-06-06 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290020682 | CARBOPLATIN + PACLITAXEL |
| 290004165 | 290003082 | 1.63 | 73.4 | Adjuvant (A) | 2013-05-03 | 2013-05-21 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 290020686 | IRINOTECAN |
| 290004166 | 290003082 | 1.68 | 65.1 | Curative (C) | 2014-04-11 | 2014-05-01 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 290020686 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 290004167 | 290007712 | 1.62 | 78 | Palliative (P) | 2014-03-18 | 2014-03-18 | Trial Unspecified | 02 | null | 290020689 | EOX |
| 290004168 | 290007712 | 1.69 | 0 | Palliative (P) | 2013-12-20 | 2013-12-20 | Capecitabine (14 days)+Carboplatin | 02 | null | 290020689 | LANREOTIDE |
| 290004169 | 290007712 | null | 62.35 | Curative (C) | 2014-05-23 | 2014-06-20 | Cetuximab + CISPLATIN + FLUOROURACIL | null | Y | 290020689 | CISPLATIN + ETOPOSIDE |
| 290004170 | 290003083 | 1.7 | null | Adjuvant (A) | 2015-12-15 | 2015-12-15 | Gemcitabine + Methylprednisolone | null | null | 290020693 | IPILIMUMAB |
| 290004171 | 290006428 | 1.62 | 60.2 | null | 2017-07-23 | 2017-08-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290020694 | CARBOPLATIN |
| 290004172 | 290003084 | null | 102.55 | Palliative (P) | 2015-01-02 | 2015-01-22 | LANREOTIDE | N | N | 290020695 | FLUOROURACIL |
| 290004173 | 290003084 | 0 | 104.9 | null | 2015-04-29 | 2015-05-02 | Capecitabine 35days + RT | N | N | 290020695 | CAPECITABINE |
| 290004174 | 290007713 | 1.9 | 60.6 | Neo-adjuvant (N) | 2016-09-10 | 2016-09-30 | Carboplatin AUC 2 - 5 | N | N | 290020698 | CISPLATIN + FLUOROURACIL |
| 290004175 | 290003085 | 1.66 | 64.5 | Palliative (P) | 2017-07-19 | 2017-07-19 | Capecitabine + Cisplatin | N | N | 290020700 | OCTREOTIDE |
| 290004176 | 290003086 | 1.51 | 51.6 | Palliative (P) | 2015-10-21 | 2015-10-21 | Carboplatin AUC 2 - 5 | 02 | N | 290020701 | FLUOROURACIL |
| 290004177 | 290003086 | 1.66 | null | Adjuvant (A) | 2016-02-04 | 2016-03-06 | Capecitabine 42days + RT | 99 | N | 290020701 | LANREOTIDE |
| 290004178 | 290003086 | null | null | Neo-adjuvant (N) | 2013-06-06 | 2013-07-04 | Capecitabine + Cisplatin | N | Y | 290020701 | CARBOPLATIN |
| 290004179 | 290003086 | 1.6 | 67.3 | Curative (C) | 2014-12-05 | 2014-12-05 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290020701 | CISPLATIN + GEMCITABINE |
| 290004180 | 290003087 | 1.74 | 56 | Curative (C) | 2016-09-12 | 2016-09-26 | Cisplatin+Gemcitabine (gallbladder) | N | Y | 290020706 | CAPECITABINE |
| 290004181 | 290003088 | 1.73 | 86.9 | Palliative (P) | 2017-11-15 | 2017-12-05 | CISPLATIN + FLUOROURACIL | N | N | 290020708 | IPILIMUMAB |
| 290004182 | 290003088 | 1.57 | 42.8 | Curative (C) | 2014-02-12 | 2014-02-13 | Capecitabine | N | null | 290020708 | CARBOPLATIN |
| 290004183 | 290003088 | 1.74 | 53 | Palliative (P) | 2015-07-08 | 2015-07-21 | Carboplatin + Pemetrexed | N | N | 290020708 | HYDROXYCARBAMIDE |
| 290004184 | 290003088 | 1.6 | 70.8 | Disease modification (D) | 2018-04-10 | 2018-05-01 | Bevacizumab + Cape + Irino 21day | N | N | 290020708 | GEMCARBO |
| 290004185 | 290003089 | 1.96 | 86.5 | Neo-adjuvant (N) | 2017-05-05 | 2017-06-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | Y | 290020712 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004186 | 290003090 | 1.6 | null | null | 2015-12-16 | 2015-12-22 | Cisplatin +Fluorouracil (3 wk) | N | null | 290020713 | CISPLATIN + FLUOROURACIL |
| 290004187 | 290003091 | 1.78 | 112 | null | 2013-07-21 | 2013-07-24 | Sunitinib | N | N | 290020714 | CAPECITABINE |
| 290004188 | 290006432 | 1.73 | 75.5 | Not known (9) | 2017-11-09 | 2017-11-25 | CHOP R - 21 days | N | N | 290020715 | CAPECITABINE |
| 290004189 | 290007716 | 1.78 | 65 | Neo-adjuvant (N) | 2017-01-18 | 2017-01-23 | Capecitabine + Streptozocin | 2 | N | 290020717 | CAPECITABINE + CISPLATIN |
| 290004190 | 290003092 | 1.62 | 78 | Palliative (P) | 2013-02-19 | 2013-02-19 | PEMBROLIZUMAB | 2 | N | 290020720 | CARBO + FLUOROURACIL |